País: Estados Unidos
Idioma: inglés
Fuente: NLM (National Library of Medicine)
LIDOCAINE HYDROCHLORIDE ANHYDROUS (UNII: EC2CNF7XFP) (LIDOCAINE - UNII:98PI200987)
Sintetica US LLC
INFILTRATION
PRESCRIPTION DRUG
Lidocaine Hydrochloride Injection is indicated for production of local or regional anesthesia by infiltration techniques such as percutaneous injection, by peripheral nerve block techniques such as brachial plexus and intercostal and by central neural techniques such as lumbar and caudal epidural blocks, when the accepted procedures for these techniques as described in standard textbooks are observed. Lidocaine HCl is contraindicated in patients with a known history of hypersensitivity to local anesthetics of the amide type.
Lidocaine Hydrochloride Injection, USP is supplied as sterile, clear colorless solution free from visible particles as follows: Lidocaine Hydrochloride Injection, 1% (10 mg per mL) Unit of sale Strength Each NDC 83090-001-10 Unit of 10 1% (20 mg per 2 mL ) (10 mg per mL) 2 mL Single-Dose Ampule NDC 83090-002-10 Unit of 10 1% (50 mg per 5 mL ) (10 mg per mL) 5 mL Single-Dose Ampule NDC 83090-003-10 Unit of 10 1% (100 mg per 10 mL ) (10 mg/mL) 10 mL Single Dose Ampule Lidocaine Hydrochloride Injection, 2% (20 mg per mL) Unit of sale Strength Each NDC 83090-004-10 Unit of 10 2% (40 mg per 2 mL ) (20 mg per mL) 2 mL Single-Dose Ampule NDC 83090-005-10 Unit of 10 2% (100 mg per 5 mL ) (20 mg per mL) 5 mL Single-Dose Ampule NDC 83090-006-10 Unit of 10 2% (200 mg per 10 mL ) (20 mg per mL) 10 mL Single Dose Ampule Sterile, Nonpyrogenic Discard unused portion Store at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.] Manufactured by: Sintetica S.A. Mendrisio Switzerland Manufactured for: Sintetica US LLC 301 Carnegie Center Suite 101 Princeton, New Jersey 08540 USA Revised: 11/2022
Abbreviated New Drug Application
NA- LIDOCAINE HYDROCHLORIDE INJECTION, SOLUTION SINTETICA US LLC ---------- LIDOCAINE HYDROCHLORIDE INJECTION, USP 1% LIDOCAINE HYDROCHLORIDE INJECTION, USP 2% FOR INFILTRATION AND NERVE BLOCK RX ONLY DESCRIPTION Lidocaine Hydrochloride Injection, USP is a sterile, nonpyrogenic, aqueous solution that contains a local anesthetic agent and is administered parenterally by injection. See INDICATIONS AND USAGEsection for specific uses.Lidocaine Hydrochloride Injection, USP solution contains lidocaine HCl, which is chemically designated as acetamide, 2- (diethylamino)-N-(2,6- dimethylphenyl)-, monohydrochloride and has the molecular wt. 270.8. Lidocaine HCl (C14H22N2O • HCl) has the following structural formula: Lidocaine Hydrochloride Injection, USP solution is for single dose usage, and is Methyl Paraben Free (Preservative-Free).Lidocaine Hydrochloride Injection, USP solution is a sterile, nonpyrogenic, isotonic solution containing sodium chloride. The pH of this solution is adjusted to approximately 6.5 (5.0 to 7.0) with sodium hydroxide and/or hydrochloric acid. CLINICAL PHARMACOLOGY _MECHANISM OF ACTION_ Lidocaine HCl stabilizes the neuronal membrane by inhibiting the ionic fluxes required for the initiation and conduction of impulses thereby effecting local anesthetic action. _HEMODYNAMICS_ Excessive blood levels may cause changes in cardiac output, total peripheral resistance, and mean arterial pressure. With central neural blockade these changes may be attributable to block of autonomic fibers, a direct depressant effect of the local anesthetic agent on various components of the cardiovascular system, and/or the beta- adrenergic receptor stimulating action of epinephrine when present. The net effect is normally a modest hypotension when the recommended dosages are not exceeded. _PHARMACOKINETICS AND METABOLISM_ Information derived from diverse formulations, concentrations and usages reveals that lidocaine HCl is completely absorbed following parenteral administration, its rate of absorption depending, for exa Leer el documento completo